Global Plasma Protein Therapeutics Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
According to our (Global Info Research) latest study, the global Plasma Protein Therapeutics market size was valued at US$ 36350 million in 2024 and is forecast to a readjusted size of USD 59680 million by 2031 with a CAGR of 7.4% during review period.
Plasma Protein Therapeutics is use blood products to treat disease.Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called blood product.
The plasma protein therapeutics market is driven by the increasing prevalence of rare and chronic diseases such as hemophilia, primary immunodeficiency, and autoimmune disorders, which require life-saving plasma-derived treatments. Advances in plasma fractionation techniques and the growing demand for immunoglobulins, albumin, and clotting factors are further fueling market growth. Additionally, improvements in diagnostic technologies have led to earlier detection and treatment of these conditions, expanding the patient pool for plasma protein therapies. Increasing awareness and access to these treatments in developing regions are also contributing to market expansion.A significant challenge in the plasma protein therapeutics market is the limited availability of plasma due to the complex and time-consuming process of plasma collection and fractionation. This often results in supply shortages, which can affect patient access to essential therapies. The high cost of plasma protein therapies, due to the labor-intensive production process and stringent regulatory requirements, also poses a barrier to treatment affordability. Furthermore, the market faces increasing competition from recombinant therapies, which are being developed as alternatives to plasma-derived products, potentially impacting market share.
Takeda, CSL and Grifolsare the leaders of the Plasma Protein Therapeutics industry, The top five manufacturers held 73.28% of the market. North America is the major region of the global market, which takes about 40% market share.
This report is a detailed and comprehensive analysis for global Plasma Protein Therapeutics market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Plasma Protein Therapeutics market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Plasma Protein Therapeutics market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Plasma Protein Therapeutics market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Plasma Protein Therapeutics market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Plasma Protein Therapeutics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Plasma Protein Therapeutics market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL, RAAS, CBPO, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Plasma Protein Therapeutics market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Plasma Protein Therapeutics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Plasma Protein Therapeutics, with price, sales quantity, revenue, and global market share of Plasma Protein Therapeutics from 2020 to 2025.
Chapter 3, the Plasma Protein Therapeutics competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Plasma Protein Therapeutics breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Plasma Protein Therapeutics market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Plasma Protein Therapeutics.
Chapter 14 and 15, to describe Plasma Protein Therapeutics sales channel, distributors, customers, research findings and conclusion.
Plasma Protein Therapeutics is use blood products to treat disease.Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called blood product.
The plasma protein therapeutics market is driven by the increasing prevalence of rare and chronic diseases such as hemophilia, primary immunodeficiency, and autoimmune disorders, which require life-saving plasma-derived treatments. Advances in plasma fractionation techniques and the growing demand for immunoglobulins, albumin, and clotting factors are further fueling market growth. Additionally, improvements in diagnostic technologies have led to earlier detection and treatment of these conditions, expanding the patient pool for plasma protein therapies. Increasing awareness and access to these treatments in developing regions are also contributing to market expansion.A significant challenge in the plasma protein therapeutics market is the limited availability of plasma due to the complex and time-consuming process of plasma collection and fractionation. This often results in supply shortages, which can affect patient access to essential therapies. The high cost of plasma protein therapies, due to the labor-intensive production process and stringent regulatory requirements, also poses a barrier to treatment affordability. Furthermore, the market faces increasing competition from recombinant therapies, which are being developed as alternatives to plasma-derived products, potentially impacting market share.
Takeda, CSL and Grifolsare the leaders of the Plasma Protein Therapeutics industry, The top five manufacturers held 73.28% of the market. North America is the major region of the global market, which takes about 40% market share.
This report is a detailed and comprehensive analysis for global Plasma Protein Therapeutics market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Plasma Protein Therapeutics market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Plasma Protein Therapeutics market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Plasma Protein Therapeutics market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Plasma Protein Therapeutics market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Plasma Protein Therapeutics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Plasma Protein Therapeutics market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL, RAAS, CBPO, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Plasma Protein Therapeutics market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Coagulation Factor
- Immune Globulin
- Albumin
- Others
- Hemophilia
- PID
- Others
- Takeda
- CSL
- Grifols
- Octapharma
- Kedrion
- LFB Group
- Biotest
- BPL
- RAAS
- CBPO
- Hualan Bio
- Tiantan Bio
- Shuanglin Bio
- Boya Bio
- Yuanda Shuyang
- Weiguang Bio
- Nanyue Bio
- KM Biologics
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Plasma Protein Therapeutics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Plasma Protein Therapeutics, with price, sales quantity, revenue, and global market share of Plasma Protein Therapeutics from 2020 to 2025.
Chapter 3, the Plasma Protein Therapeutics competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Plasma Protein Therapeutics breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Plasma Protein Therapeutics market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Plasma Protein Therapeutics.
Chapter 14 and 15, to describe Plasma Protein Therapeutics sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Plasma Protein Therapeutics Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Coagulation Factor
1.3.3 Immune Globulin
1.3.4 Albumin
1.3.5 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Plasma Protein Therapeutics Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hemophilia
1.4.3 PID
1.4.4 Others
1.5 Global Plasma Protein Therapeutics Market Size & Forecast
1.5.1 Global Plasma Protein Therapeutics Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Plasma Protein Therapeutics Sales Quantity (2020-2031)
1.5.3 Global Plasma Protein Therapeutics Average Price (2020-2031)
2 MANUFACTURERS PROFILES
2.1 Takeda
2.1.1 Takeda Details
2.1.2 Takeda Major Business
2.1.3 Takeda Plasma Protein Therapeutics Product and Services
2.1.4 Takeda Plasma Protein Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Takeda Recent Developments/Updates
2.2 CSL
2.2.1 CSL Details
2.2.2 CSL Major Business
2.2.3 CSL Plasma Protein Therapeutics Product and Services
2.2.4 CSL Plasma Protein Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 CSL Recent Developments/Updates
2.3 Grifols
2.3.1 Grifols Details
2.3.2 Grifols Major Business
2.3.3 Grifols Plasma Protein Therapeutics Product and Services
2.3.4 Grifols Plasma Protein Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Grifols Recent Developments/Updates
2.4 Octapharma
2.4.1 Octapharma Details
2.4.2 Octapharma Major Business
2.4.3 Octapharma Plasma Protein Therapeutics Product and Services
2.4.4 Octapharma Plasma Protein Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Octapharma Recent Developments/Updates
2.5 Kedrion
2.5.1 Kedrion Details
2.5.2 Kedrion Major Business
2.5.3 Kedrion Plasma Protein Therapeutics Product and Services
2.5.4 Kedrion Plasma Protein Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Kedrion Recent Developments/Updates
2.6 LFB Group
2.6.1 LFB Group Details
2.6.2 LFB Group Major Business
2.6.3 LFB Group Plasma Protein Therapeutics Product and Services
2.6.4 LFB Group Plasma Protein Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 LFB Group Recent Developments/Updates
2.7 Biotest
2.7.1 Biotest Details
2.7.2 Biotest Major Business
2.7.3 Biotest Plasma Protein Therapeutics Product and Services
2.7.4 Biotest Plasma Protein Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Biotest Recent Developments/Updates
2.8 BPL
2.8.1 BPL Details
2.8.2 BPL Major Business
2.8.3 BPL Plasma Protein Therapeutics Product and Services
2.8.4 BPL Plasma Protein Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 BPL Recent Developments/Updates
2.9 RAAS
2.9.1 RAAS Details
2.9.2 RAAS Major Business
2.9.3 RAAS Plasma Protein Therapeutics Product and Services
2.9.4 RAAS Plasma Protein Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 RAAS Recent Developments/Updates
2.10 CBPO
2.10.1 CBPO Details
2.10.2 CBPO Major Business
2.10.3 CBPO Plasma Protein Therapeutics Product and Services
2.10.4 CBPO Plasma Protein Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 CBPO Recent Developments/Updates
2.11 Hualan Bio
2.11.1 Hualan Bio Details
2.11.2 Hualan Bio Major Business
2.11.3 Hualan Bio Plasma Protein Therapeutics Product and Services
2.11.4 Hualan Bio Plasma Protein Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Hualan Bio Recent Developments/Updates
2.12 Tiantan Bio
2.12.1 Tiantan Bio Details
2.12.2 Tiantan Bio Major Business
2.12.3 Tiantan Bio Plasma Protein Therapeutics Product and Services
2.12.4 Tiantan Bio Plasma Protein Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Tiantan Bio Recent Developments/Updates
2.13 Shuanglin Bio
2.13.1 Shuanglin Bio Details
2.13.2 Shuanglin Bio Major Business
2.13.3 Shuanglin Bio Plasma Protein Therapeutics Product and Services
2.13.4 Shuanglin Bio Plasma Protein Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Shuanglin Bio Recent Developments/Updates
2.14 Boya Bio
2.14.1 Boya Bio Details
2.14.2 Boya Bio Major Business
2.14.3 Boya Bio Plasma Protein Therapeutics Product and Services
2.14.4 Boya Bio Plasma Protein Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 Boya Bio Recent Developments/Updates
2.15 Yuanda Shuyang
2.15.1 Yuanda Shuyang Details
2.15.2 Yuanda Shuyang Major Business
2.15.3 Yuanda Shuyang Plasma Protein Therapeutics Product and Services
2.15.4 Yuanda Shuyang Plasma Protein Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 Yuanda Shuyang Recent Developments/Updates
2.16 Weiguang Bio
2.16.1 Weiguang Bio Details
2.16.2 Weiguang Bio Major Business
2.16.3 Weiguang Bio Plasma Protein Therapeutics Product and Services
2.16.4 Weiguang Bio Plasma Protein Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.16.5 Weiguang Bio Recent Developments/Updates
2.17 Nanyue Bio
2.17.1 Nanyue Bio Details
2.17.2 Nanyue Bio Major Business
2.17.3 Nanyue Bio Plasma Protein Therapeutics Product and Services
2.17.4 Nanyue Bio Plasma Protein Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.17.5 Nanyue Bio Recent Developments/Updates
2.18 KM Biologics
2.18.1 KM Biologics Details
2.18.2 KM Biologics Major Business
2.18.3 KM Biologics Plasma Protein Therapeutics Product and Services
2.18.4 KM Biologics Plasma Protein Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.18.5 KM Biologics Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: PLASMA PROTEIN THERAPEUTICS BY MANUFACTURER
3.1 Global Plasma Protein Therapeutics Sales Quantity by Manufacturer (2020-2025)
3.2 Global Plasma Protein Therapeutics Revenue by Manufacturer (2020-2025)
3.3 Global Plasma Protein Therapeutics Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Plasma Protein Therapeutics by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Plasma Protein Therapeutics Manufacturer Market Share in 2024
3.4.3 Top 6 Plasma Protein Therapeutics Manufacturer Market Share in 2024
3.5 Plasma Protein Therapeutics Market: Overall Company Footprint Analysis
3.5.1 Plasma Protein Therapeutics Market: Region Footprint
3.5.2 Plasma Protein Therapeutics Market: Company Product Type Footprint
3.5.3 Plasma Protein Therapeutics Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Plasma Protein Therapeutics Market Size by Region
4.1.1 Global Plasma Protein Therapeutics Sales Quantity by Region (2020-2031)
4.1.2 Global Plasma Protein Therapeutics Consumption Value by Region (2020-2031)
4.1.3 Global Plasma Protein Therapeutics Average Price by Region (2020-2031)
4.2 North America Plasma Protein Therapeutics Consumption Value (2020-2031)
4.3 Europe Plasma Protein Therapeutics Consumption Value (2020-2031)
4.4 Asia-Pacific Plasma Protein Therapeutics Consumption Value (2020-2031)
4.5 South America Plasma Protein Therapeutics Consumption Value (2020-2031)
4.6 Middle East & Africa Plasma Protein Therapeutics Consumption Value (2020-2031)
5 MARKET SEGMENT BY TYPE
5.1 Global Plasma Protein Therapeutics Sales Quantity by Type (2020-2031)
5.2 Global Plasma Protein Therapeutics Consumption Value by Type (2020-2031)
5.3 Global Plasma Protein Therapeutics Average Price by Type (2020-2031)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Plasma Protein Therapeutics Sales Quantity by Application (2020-2031)
6.2 Global Plasma Protein Therapeutics Consumption Value by Application (2020-2031)
6.3 Global Plasma Protein Therapeutics Average Price by Application (2020-2031)
7 NORTH AMERICA
7.1 North America Plasma Protein Therapeutics Sales Quantity by Type (2020-2031)
7.2 North America Plasma Protein Therapeutics Sales Quantity by Application (2020-2031)
7.3 North America Plasma Protein Therapeutics Market Size by Country
7.3.1 North America Plasma Protein Therapeutics Sales Quantity by Country (2020-2031)
7.3.2 North America Plasma Protein Therapeutics Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 EUROPE
8.1 Europe Plasma Protein Therapeutics Sales Quantity by Type (2020-2031)
8.2 Europe Plasma Protein Therapeutics Sales Quantity by Application (2020-2031)
8.3 Europe Plasma Protein Therapeutics Market Size by Country
8.3.1 Europe Plasma Protein Therapeutics Sales Quantity by Country (2020-2031)
8.3.2 Europe Plasma Protein Therapeutics Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 ASIA-PACIFIC
9.1 Asia-Pacific Plasma Protein Therapeutics Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Plasma Protein Therapeutics Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Plasma Protein Therapeutics Market Size by Region
9.3.1 Asia-Pacific Plasma Protein Therapeutics Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Plasma Protein Therapeutics Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 SOUTH AMERICA
10.1 South America Plasma Protein Therapeutics Sales Quantity by Type (2020-2031)
10.2 South America Plasma Protein Therapeutics Sales Quantity by Application (2020-2031)
10.3 South America Plasma Protein Therapeutics Market Size by Country
10.3.1 South America Plasma Protein Therapeutics Sales Quantity by Country (2020-2031)
10.3.2 South America Plasma Protein Therapeutics Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Plasma Protein Therapeutics Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Plasma Protein Therapeutics Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Plasma Protein Therapeutics Market Size by Country
11.3.1 Middle East & Africa Plasma Protein Therapeutics Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Plasma Protein Therapeutics Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 MARKET DYNAMICS
12.1 Plasma Protein Therapeutics Market Drivers
12.2 Plasma Protein Therapeutics Market Restraints
12.3 Plasma Protein Therapeutics Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Plasma Protein Therapeutics and Key Manufacturers
13.2 Manufacturing Costs Percentage of Plasma Protein Therapeutics
13.3 Plasma Protein Therapeutics Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Plasma Protein Therapeutics Typical Distributors
14.3 Plasma Protein Therapeutics Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Plasma Protein Therapeutics Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Coagulation Factor
1.3.3 Immune Globulin
1.3.4 Albumin
1.3.5 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Plasma Protein Therapeutics Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hemophilia
1.4.3 PID
1.4.4 Others
1.5 Global Plasma Protein Therapeutics Market Size & Forecast
1.5.1 Global Plasma Protein Therapeutics Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Plasma Protein Therapeutics Sales Quantity (2020-2031)
1.5.3 Global Plasma Protein Therapeutics Average Price (2020-2031)
2 MANUFACTURERS PROFILES
2.1 Takeda
2.1.1 Takeda Details
2.1.2 Takeda Major Business
2.1.3 Takeda Plasma Protein Therapeutics Product and Services
2.1.4 Takeda Plasma Protein Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Takeda Recent Developments/Updates
2.2 CSL
2.2.1 CSL Details
2.2.2 CSL Major Business
2.2.3 CSL Plasma Protein Therapeutics Product and Services
2.2.4 CSL Plasma Protein Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 CSL Recent Developments/Updates
2.3 Grifols
2.3.1 Grifols Details
2.3.2 Grifols Major Business
2.3.3 Grifols Plasma Protein Therapeutics Product and Services
2.3.4 Grifols Plasma Protein Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Grifols Recent Developments/Updates
2.4 Octapharma
2.4.1 Octapharma Details
2.4.2 Octapharma Major Business
2.4.3 Octapharma Plasma Protein Therapeutics Product and Services
2.4.4 Octapharma Plasma Protein Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Octapharma Recent Developments/Updates
2.5 Kedrion
2.5.1 Kedrion Details
2.5.2 Kedrion Major Business
2.5.3 Kedrion Plasma Protein Therapeutics Product and Services
2.5.4 Kedrion Plasma Protein Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Kedrion Recent Developments/Updates
2.6 LFB Group
2.6.1 LFB Group Details
2.6.2 LFB Group Major Business
2.6.3 LFB Group Plasma Protein Therapeutics Product and Services
2.6.4 LFB Group Plasma Protein Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 LFB Group Recent Developments/Updates
2.7 Biotest
2.7.1 Biotest Details
2.7.2 Biotest Major Business
2.7.3 Biotest Plasma Protein Therapeutics Product and Services
2.7.4 Biotest Plasma Protein Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Biotest Recent Developments/Updates
2.8 BPL
2.8.1 BPL Details
2.8.2 BPL Major Business
2.8.3 BPL Plasma Protein Therapeutics Product and Services
2.8.4 BPL Plasma Protein Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 BPL Recent Developments/Updates
2.9 RAAS
2.9.1 RAAS Details
2.9.2 RAAS Major Business
2.9.3 RAAS Plasma Protein Therapeutics Product and Services
2.9.4 RAAS Plasma Protein Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 RAAS Recent Developments/Updates
2.10 CBPO
2.10.1 CBPO Details
2.10.2 CBPO Major Business
2.10.3 CBPO Plasma Protein Therapeutics Product and Services
2.10.4 CBPO Plasma Protein Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 CBPO Recent Developments/Updates
2.11 Hualan Bio
2.11.1 Hualan Bio Details
2.11.2 Hualan Bio Major Business
2.11.3 Hualan Bio Plasma Protein Therapeutics Product and Services
2.11.4 Hualan Bio Plasma Protein Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Hualan Bio Recent Developments/Updates
2.12 Tiantan Bio
2.12.1 Tiantan Bio Details
2.12.2 Tiantan Bio Major Business
2.12.3 Tiantan Bio Plasma Protein Therapeutics Product and Services
2.12.4 Tiantan Bio Plasma Protein Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Tiantan Bio Recent Developments/Updates
2.13 Shuanglin Bio
2.13.1 Shuanglin Bio Details
2.13.2 Shuanglin Bio Major Business
2.13.3 Shuanglin Bio Plasma Protein Therapeutics Product and Services
2.13.4 Shuanglin Bio Plasma Protein Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Shuanglin Bio Recent Developments/Updates
2.14 Boya Bio
2.14.1 Boya Bio Details
2.14.2 Boya Bio Major Business
2.14.3 Boya Bio Plasma Protein Therapeutics Product and Services
2.14.4 Boya Bio Plasma Protein Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 Boya Bio Recent Developments/Updates
2.15 Yuanda Shuyang
2.15.1 Yuanda Shuyang Details
2.15.2 Yuanda Shuyang Major Business
2.15.3 Yuanda Shuyang Plasma Protein Therapeutics Product and Services
2.15.4 Yuanda Shuyang Plasma Protein Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 Yuanda Shuyang Recent Developments/Updates
2.16 Weiguang Bio
2.16.1 Weiguang Bio Details
2.16.2 Weiguang Bio Major Business
2.16.3 Weiguang Bio Plasma Protein Therapeutics Product and Services
2.16.4 Weiguang Bio Plasma Protein Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.16.5 Weiguang Bio Recent Developments/Updates
2.17 Nanyue Bio
2.17.1 Nanyue Bio Details
2.17.2 Nanyue Bio Major Business
2.17.3 Nanyue Bio Plasma Protein Therapeutics Product and Services
2.17.4 Nanyue Bio Plasma Protein Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.17.5 Nanyue Bio Recent Developments/Updates
2.18 KM Biologics
2.18.1 KM Biologics Details
2.18.2 KM Biologics Major Business
2.18.3 KM Biologics Plasma Protein Therapeutics Product and Services
2.18.4 KM Biologics Plasma Protein Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.18.5 KM Biologics Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: PLASMA PROTEIN THERAPEUTICS BY MANUFACTURER
3.1 Global Plasma Protein Therapeutics Sales Quantity by Manufacturer (2020-2025)
3.2 Global Plasma Protein Therapeutics Revenue by Manufacturer (2020-2025)
3.3 Global Plasma Protein Therapeutics Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Plasma Protein Therapeutics by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Plasma Protein Therapeutics Manufacturer Market Share in 2024
3.4.3 Top 6 Plasma Protein Therapeutics Manufacturer Market Share in 2024
3.5 Plasma Protein Therapeutics Market: Overall Company Footprint Analysis
3.5.1 Plasma Protein Therapeutics Market: Region Footprint
3.5.2 Plasma Protein Therapeutics Market: Company Product Type Footprint
3.5.3 Plasma Protein Therapeutics Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Plasma Protein Therapeutics Market Size by Region
4.1.1 Global Plasma Protein Therapeutics Sales Quantity by Region (2020-2031)
4.1.2 Global Plasma Protein Therapeutics Consumption Value by Region (2020-2031)
4.1.3 Global Plasma Protein Therapeutics Average Price by Region (2020-2031)
4.2 North America Plasma Protein Therapeutics Consumption Value (2020-2031)
4.3 Europe Plasma Protein Therapeutics Consumption Value (2020-2031)
4.4 Asia-Pacific Plasma Protein Therapeutics Consumption Value (2020-2031)
4.5 South America Plasma Protein Therapeutics Consumption Value (2020-2031)
4.6 Middle East & Africa Plasma Protein Therapeutics Consumption Value (2020-2031)
5 MARKET SEGMENT BY TYPE
5.1 Global Plasma Protein Therapeutics Sales Quantity by Type (2020-2031)
5.2 Global Plasma Protein Therapeutics Consumption Value by Type (2020-2031)
5.3 Global Plasma Protein Therapeutics Average Price by Type (2020-2031)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Plasma Protein Therapeutics Sales Quantity by Application (2020-2031)
6.2 Global Plasma Protein Therapeutics Consumption Value by Application (2020-2031)
6.3 Global Plasma Protein Therapeutics Average Price by Application (2020-2031)
7 NORTH AMERICA
7.1 North America Plasma Protein Therapeutics Sales Quantity by Type (2020-2031)
7.2 North America Plasma Protein Therapeutics Sales Quantity by Application (2020-2031)
7.3 North America Plasma Protein Therapeutics Market Size by Country
7.3.1 North America Plasma Protein Therapeutics Sales Quantity by Country (2020-2031)
7.3.2 North America Plasma Protein Therapeutics Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 EUROPE
8.1 Europe Plasma Protein Therapeutics Sales Quantity by Type (2020-2031)
8.2 Europe Plasma Protein Therapeutics Sales Quantity by Application (2020-2031)
8.3 Europe Plasma Protein Therapeutics Market Size by Country
8.3.1 Europe Plasma Protein Therapeutics Sales Quantity by Country (2020-2031)
8.3.2 Europe Plasma Protein Therapeutics Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 ASIA-PACIFIC
9.1 Asia-Pacific Plasma Protein Therapeutics Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Plasma Protein Therapeutics Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Plasma Protein Therapeutics Market Size by Region
9.3.1 Asia-Pacific Plasma Protein Therapeutics Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Plasma Protein Therapeutics Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 SOUTH AMERICA
10.1 South America Plasma Protein Therapeutics Sales Quantity by Type (2020-2031)
10.2 South America Plasma Protein Therapeutics Sales Quantity by Application (2020-2031)
10.3 South America Plasma Protein Therapeutics Market Size by Country
10.3.1 South America Plasma Protein Therapeutics Sales Quantity by Country (2020-2031)
10.3.2 South America Plasma Protein Therapeutics Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Plasma Protein Therapeutics Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Plasma Protein Therapeutics Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Plasma Protein Therapeutics Market Size by Country
11.3.1 Middle East & Africa Plasma Protein Therapeutics Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Plasma Protein Therapeutics Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 MARKET DYNAMICS
12.1 Plasma Protein Therapeutics Market Drivers
12.2 Plasma Protein Therapeutics Market Restraints
12.3 Plasma Protein Therapeutics Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Plasma Protein Therapeutics and Key Manufacturers
13.2 Manufacturing Costs Percentage of Plasma Protein Therapeutics
13.3 Plasma Protein Therapeutics Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Plasma Protein Therapeutics Typical Distributors
14.3 Plasma Protein Therapeutics Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Plasma Protein Therapeutics Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Plasma Protein Therapeutics Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Takeda Basic Information, Manufacturing Base and Competitors
Table 4. Takeda Major Business
Table 5. Takeda Plasma Protein Therapeutics Product and Services
Table 6. Takeda Plasma Protein Therapeutics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. Takeda Recent Developments/Updates
Table 8. CSL Basic Information, Manufacturing Base and Competitors
Table 9. CSL Major Business
Table 10. CSL Plasma Protein Therapeutics Product and Services
Table 11. CSL Plasma Protein Therapeutics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. CSL Recent Developments/Updates
Table 13. Grifols Basic Information, Manufacturing Base and Competitors
Table 14. Grifols Major Business
Table 15. Grifols Plasma Protein Therapeutics Product and Services
Table 16. Grifols Plasma Protein Therapeutics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. Grifols Recent Developments/Updates
Table 18. Octapharma Basic Information, Manufacturing Base and Competitors
Table 19. Octapharma Major Business
Table 20. Octapharma Plasma Protein Therapeutics Product and Services
Table 21. Octapharma Plasma Protein Therapeutics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. Octapharma Recent Developments/Updates
Table 23. Kedrion Basic Information, Manufacturing Base and Competitors
Table 24. Kedrion Major Business
Table 25. Kedrion Plasma Protein Therapeutics Product and Services
Table 26. Kedrion Plasma Protein Therapeutics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27. Kedrion Recent Developments/Updates
Table 28. LFB Group Basic Information, Manufacturing Base and Competitors
Table 29. LFB Group Major Business
Table 30. LFB Group Plasma Protein Therapeutics Product and Services
Table 31. LFB Group Plasma Protein Therapeutics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. LFB Group Recent Developments/Updates
Table 33. Biotest Basic Information, Manufacturing Base and Competitors
Table 34. Biotest Major Business
Table 35. Biotest Plasma Protein Therapeutics Product and Services
Table 36. Biotest Plasma Protein Therapeutics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 37. Biotest Recent Developments/Updates
Table 38. BPL Basic Information, Manufacturing Base and Competitors
Table 39. BPL Major Business
Table 40. BPL Plasma Protein Therapeutics Product and Services
Table 41. BPL Plasma Protein Therapeutics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 42. BPL Recent Developments/Updates
Table 43. RAAS Basic Information, Manufacturing Base and Competitors
Table 44. RAAS Major Business
Table 45. RAAS Plasma Protein Therapeutics Product and Services
Table 46. RAAS Plasma Protein Therapeutics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 47. RAAS Recent Developments/Updates
Table 48. CBPO Basic Information, Manufacturing Base and Competitors
Table 49. CBPO Major Business
Table 50. CBPO Plasma Protein Therapeutics Product and Services
Table 51. CBPO Plasma Protein Therapeutics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 52. CBPO Recent Developments/Updates
Table 53. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 54. Hualan Bio Major Business
Table 55. Hualan Bio Plasma Protein Therapeutics Product and Services
Table 56. Hualan Bio Plasma Protein Therapeutics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 57. Hualan Bio Recent Developments/Updates
Table 58. Tiantan Bio Basic Information, Manufacturing Base and Competitors
Table 59. Tiantan Bio Major Business
Table 60. Tiantan Bio Plasma Protein Therapeutics Product and Services
Table 61. Tiantan Bio Plasma Protein Therapeutics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 62. Tiantan Bio Recent Developments/Updates
Table 63. Shuanglin Bio Basic Information, Manufacturing Base and Competitors
Table 64. Shuanglin Bio Major Business
Table 65. Shuanglin Bio Plasma Protein Therapeutics Product and Services
Table 66. Shuanglin Bio Plasma Protein Therapeutics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 67. Shuanglin Bio Recent Developments/Updates
Table 68. Boya Bio Basic Information, Manufacturing Base and Competitors
Table 69. Boya Bio Major Business
Table 70. Boya Bio Plasma Protein Therapeutics Product and Services
Table 71. Boya Bio Plasma Protein Therapeutics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 72. Boya Bio Recent Developments/Updates
Table 73. Yuanda Shuyang Basic Information, Manufacturing Base and Competitors
Table 74. Yuanda Shuyang Major Business
Table 75. Yuanda Shuyang Plasma Protein Therapeutics Product and Services
Table 76. Yuanda Shuyang Plasma Protein Therapeutics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 77. Yuanda Shuyang Recent Developments/Updates
Table 78. Weiguang Bio Basic Information, Manufacturing Base and Competitors
Table 79. Weiguang Bio Major Business
Table 80. Weiguang Bio Plasma Protein Therapeutics Product and Services
Table 81. Weiguang Bio Plasma Protein Therapeutics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 82. Weiguang Bio Recent Developments/Updates
Table 83. Nanyue Bio Basic Information, Manufacturing Base and Competitors
Table 84. Nanyue Bio Major Business
Table 85. Nanyue Bio Plasma Protein Therapeutics Product and Services
Table 86. Nanyue Bio Plasma Protein Therapeutics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 87. Nanyue Bio Recent Developments/Updates
Table 88. KM Biologics Basic Information, Manufacturing Base and Competitors
Table 89. KM Biologics Major Business
Table 90. KM Biologics Plasma Protein Therapeutics Product and Services
Table 91. KM Biologics Plasma Protein Therapeutics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 92. KM Biologics Recent Developments/Updates
Table 93. Global Plasma Protein Therapeutics Sales Quantity by Manufacturer (2020-2025) & (K Units)
Table 94. Global Plasma Protein Therapeutics Revenue by Manufacturer (2020-2025) & (USD Million)
Table 95. Global Plasma Protein Therapeutics Average Price by Manufacturer (2020-2025) & (USD/Unit)
Table 96. Market Position of Manufacturers in Plasma Protein Therapeutics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 97. Head Office and Plasma Protein Therapeutics Production Site of Key Manufacturer
Table 98. Plasma Protein Therapeutics Market: Company Product Type Footprint
Table 99. Plasma Protein Therapeutics Market: Company Product Application Footprint
Table 100. Plasma Protein Therapeutics New Market Entrants and Barriers to Market Entry
Table 101. Plasma Protein Therapeutics Mergers, Acquisition, Agreements, and Collaborations
Table 102. Global Plasma Protein Therapeutics Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 103. Global Plasma Protein Therapeutics Sales Quantity by Region (2020-2025) & (K Units)
Table 104. Global Plasma Protein Therapeutics Sales Quantity by Region (2026-2031) & (K Units)
Table 105. Global Plasma Protein Therapeutics Consumption Value by Region (2020-2025) & (USD Million)
Table 106. Global Plasma Protein Therapeutics Consumption Value by Region (2026-2031) & (USD Million)
Table 107. Global Plasma Protein Therapeutics Average Price by Region (2020-2025) & (USD/Unit)
Table 108. Global Plasma Protein Therapeutics Average Price by Region (2026-2031) & (USD/Unit)
Table 109. Global Plasma Protein Therapeutics Sales Quantity by Type (2020-2025) & (K Units)
Table 110. Global Plasma Protein Therapeutics Sales Quantity by Type (2026-2031) & (K Units)
Table 111. Global Plasma Protein Therapeutics Consumption Value by Type (2020-2025) & (USD Million)
Table 112. Global Plasma Protein Therapeutics Consumption Value by Type (2026-2031) & (USD Million)
Table 113. Global Plasma Protein Therapeutics Average Price by Type (2020-2025) & (USD/Unit)
Table 114. Global Plasma Protein Therapeutics Average Price by Type (2026-2031) & (USD/Unit)
Table 115. Global Plasma Protein Therapeutics Sales Quantity by Application (2020-2025) & (K Units)
Table 116. Global Plasma Protein Therapeutics Sales Quantity by Application (2026-2031) & (K Units)
Table 117. Global Plasma Protein Therapeutics Consumption Value by Application (2020-2025) & (USD Million)
Table 118. Global Plasma Protein Therapeutics Consumption Value by Application (2026-2031) & (USD Million)
Table 119. Global Plasma Protein Therapeutics Average Price by Application (2020-2025) & (USD/Unit)
Table 120. Global Plasma Protein Therapeutics Average Price by Application (2026-2031) & (USD/Unit)
Table 121. North America Plasma Protein Therapeutics Sales Quantity by Type (2020-2025) & (K Units)
Table 122. North America Plasma Protein Therapeutics Sales Quantity by Type (2026-2031) & (K Units)
Table 123. North America Plasma Protein Therapeutics Sales Quantity by Application (2020-2025) & (K Units)
Table 124. North America Plasma Protein Therapeutics Sales Quantity by Application (2026-2031) & (K Units)
Table 125. North America Plasma Protein Therapeutics Sales Quantity by Country (2020-2025) & (K Units)
Table 126. North America Plasma Protein Therapeutics Sales Quantity by Country (2026-2031) & (K Units)
Table 127. North America Plasma Protein Therapeutics Consumption Value by Country (2020-2025) & (USD Million)
Table 128. North America Plasma Protein Therapeutics Consumption Value by Country (2026-2031) & (USD Million)
Table 129. Europe Plasma Protein Therapeutics Sales Quantity by Type (2020-2025) & (K Units)
Table 130. Europe Plasma Protein Therapeutics Sales Quantity by Type (2026-2031) & (K Units)
Table 131. Europe Plasma Protein Therapeutics Sales Quantity by Application (2020-2025) & (K Units)
Table 132. Europe Plasma Protein Therapeutics Sales Quantity by Application (2026-2031) & (K Units)
Table 133. Europe Plasma Protein Therapeutics Sales Quantity by Country (2020-2025) & (K Units)
Table 134. Europe Plasma Protein Therapeutics Sales Quantity by Country (2026-2031) & (K Units)
Table 135. Europe Plasma Protein Therapeutics Consumption Value by Country (2020-2025) & (USD Million)
Table 136. Europe Plasma Protein Therapeutics Consumption Value by Country (2026-2031) & (USD Million)
Table 137. Asia-Pacific Plasma Protein Therapeutics Sales Quantity by Type (2020-2025) & (K Units)
Table 138. Asia-Pacific Plasma Protein Therapeutics Sales Quantity by Type (2026-2031) & (K Units)
Table 139. Asia-Pacific Plasma Protein Therapeutics Sales Quantity by Application (2020-2025) & (K Units)
Table 140. Asia-Pacific Plasma Protein Therapeutics Sales Quantity by Application (2026-2031) & (K Units)
Table 141. Asia-Pacific Plasma Protein Therapeutics Sales Quantity by Region (2020-2025) & (K Units)
Table 142. Asia-Pacific Plasma Protein Therapeutics Sales Quantity by Region (2026-2031) & (K Units)
Table 143. Asia-Pacific Plasma Protein Therapeutics Consumption Value by Region (2020-2025) & (USD Million)
Table 144. Asia-Pacific Plasma Protein Therapeutics Consumption Value by Region (2026-2031) & (USD Million)
Table 145. South America Plasma Protein Therapeutics Sales Quantity by Type (2020-2025) & (K Units)
Table 146. South America Plasma Protein Therapeutics Sales Quantity by Type (2026-2031) & (K Units)
Table 147. South America Plasma Protein Therapeutics Sales Quantity by Application (2020-2025) & (K Units)
Table 148. South America Plasma Protein Therapeutics Sales Quantity by Application (2026-2031) & (K Units)
Table 149. South America Plasma Protein Therapeutics Sales Quantity by Country (2020-2025) & (K Units)
Table 150. South America Plasma Protein Therapeutics Sales Quantity by Country (2026-2031) & (K Units)
Table 151. South America Plasma Protein Therapeutics Consumption Value by Country (2020-2025) & (USD Million)
Table 152. South America Plasma Protein Therapeutics Consumption Value by Country (2026-2031) & (USD Million)
Table 153. Middle East & Africa Plasma Protein Therapeutics Sales Quantity by Type (2020-2025) & (K Units)
Table 154. Middle East & Africa Plasma Protein Therapeutics Sales Quantity by Type (2026-2031) & (K Units)
Table 155. Middle East & Africa Plasma Protein Therapeutics Sales Quantity by Application (2020-2025) & (K Units)
Table 156. Middle East & Africa Plasma Protein Therapeutics Sales Quantity by Application (2026-2031) & (K Units)
Table 157. Middle East & Africa Plasma Protein Therapeutics Sales Quantity by Country (2020-2025) & (K Units)
Table 158. Middle East & Africa Plasma Protein Therapeutics Sales Quantity by Country (2026-2031) & (K Units)
Table 159. Middle East & Africa Plasma Protein Therapeutics Consumption Value by Country (2020-2025) & (USD Million)
Table 160. Middle East & Africa Plasma Protein Therapeutics Consumption Value by Country (2026-2031) & (USD Million)
Table 161. Plasma Protein Therapeutics Raw Material
Table 162. Key Manufacturers of Plasma Protein Therapeutics Raw Materials
Table 163. Plasma Protein Therapeutics Typical Distributors
Table 164. Plasma Protein Therapeutics Typical Customers
Table 1. Global Plasma Protein Therapeutics Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Plasma Protein Therapeutics Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Takeda Basic Information, Manufacturing Base and Competitors
Table 4. Takeda Major Business
Table 5. Takeda Plasma Protein Therapeutics Product and Services
Table 6. Takeda Plasma Protein Therapeutics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. Takeda Recent Developments/Updates
Table 8. CSL Basic Information, Manufacturing Base and Competitors
Table 9. CSL Major Business
Table 10. CSL Plasma Protein Therapeutics Product and Services
Table 11. CSL Plasma Protein Therapeutics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. CSL Recent Developments/Updates
Table 13. Grifols Basic Information, Manufacturing Base and Competitors
Table 14. Grifols Major Business
Table 15. Grifols Plasma Protein Therapeutics Product and Services
Table 16. Grifols Plasma Protein Therapeutics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. Grifols Recent Developments/Updates
Table 18. Octapharma Basic Information, Manufacturing Base and Competitors
Table 19. Octapharma Major Business
Table 20. Octapharma Plasma Protein Therapeutics Product and Services
Table 21. Octapharma Plasma Protein Therapeutics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. Octapharma Recent Developments/Updates
Table 23. Kedrion Basic Information, Manufacturing Base and Competitors
Table 24. Kedrion Major Business
Table 25. Kedrion Plasma Protein Therapeutics Product and Services
Table 26. Kedrion Plasma Protein Therapeutics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27. Kedrion Recent Developments/Updates
Table 28. LFB Group Basic Information, Manufacturing Base and Competitors
Table 29. LFB Group Major Business
Table 30. LFB Group Plasma Protein Therapeutics Product and Services
Table 31. LFB Group Plasma Protein Therapeutics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. LFB Group Recent Developments/Updates
Table 33. Biotest Basic Information, Manufacturing Base and Competitors
Table 34. Biotest Major Business
Table 35. Biotest Plasma Protein Therapeutics Product and Services
Table 36. Biotest Plasma Protein Therapeutics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 37. Biotest Recent Developments/Updates
Table 38. BPL Basic Information, Manufacturing Base and Competitors
Table 39. BPL Major Business
Table 40. BPL Plasma Protein Therapeutics Product and Services
Table 41. BPL Plasma Protein Therapeutics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 42. BPL Recent Developments/Updates
Table 43. RAAS Basic Information, Manufacturing Base and Competitors
Table 44. RAAS Major Business
Table 45. RAAS Plasma Protein Therapeutics Product and Services
Table 46. RAAS Plasma Protein Therapeutics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 47. RAAS Recent Developments/Updates
Table 48. CBPO Basic Information, Manufacturing Base and Competitors
Table 49. CBPO Major Business
Table 50. CBPO Plasma Protein Therapeutics Product and Services
Table 51. CBPO Plasma Protein Therapeutics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 52. CBPO Recent Developments/Updates
Table 53. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 54. Hualan Bio Major Business
Table 55. Hualan Bio Plasma Protein Therapeutics Product and Services
Table 56. Hualan Bio Plasma Protein Therapeutics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 57. Hualan Bio Recent Developments/Updates
Table 58. Tiantan Bio Basic Information, Manufacturing Base and Competitors
Table 59. Tiantan Bio Major Business
Table 60. Tiantan Bio Plasma Protein Therapeutics Product and Services
Table 61. Tiantan Bio Plasma Protein Therapeutics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 62. Tiantan Bio Recent Developments/Updates
Table 63. Shuanglin Bio Basic Information, Manufacturing Base and Competitors
Table 64. Shuanglin Bio Major Business
Table 65. Shuanglin Bio Plasma Protein Therapeutics Product and Services
Table 66. Shuanglin Bio Plasma Protein Therapeutics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 67. Shuanglin Bio Recent Developments/Updates
Table 68. Boya Bio Basic Information, Manufacturing Base and Competitors
Table 69. Boya Bio Major Business
Table 70. Boya Bio Plasma Protein Therapeutics Product and Services
Table 71. Boya Bio Plasma Protein Therapeutics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 72. Boya Bio Recent Developments/Updates
Table 73. Yuanda Shuyang Basic Information, Manufacturing Base and Competitors
Table 74. Yuanda Shuyang Major Business
Table 75. Yuanda Shuyang Plasma Protein Therapeutics Product and Services
Table 76. Yuanda Shuyang Plasma Protein Therapeutics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 77. Yuanda Shuyang Recent Developments/Updates
Table 78. Weiguang Bio Basic Information, Manufacturing Base and Competitors
Table 79. Weiguang Bio Major Business
Table 80. Weiguang Bio Plasma Protein Therapeutics Product and Services
Table 81. Weiguang Bio Plasma Protein Therapeutics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 82. Weiguang Bio Recent Developments/Updates
Table 83. Nanyue Bio Basic Information, Manufacturing Base and Competitors
Table 84. Nanyue Bio Major Business
Table 85. Nanyue Bio Plasma Protein Therapeutics Product and Services
Table 86. Nanyue Bio Plasma Protein Therapeutics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 87. Nanyue Bio Recent Developments/Updates
Table 88. KM Biologics Basic Information, Manufacturing Base and Competitors
Table 89. KM Biologics Major Business
Table 90. KM Biologics Plasma Protein Therapeutics Product and Services
Table 91. KM Biologics Plasma Protein Therapeutics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 92. KM Biologics Recent Developments/Updates
Table 93. Global Plasma Protein Therapeutics Sales Quantity by Manufacturer (2020-2025) & (K Units)
Table 94. Global Plasma Protein Therapeutics Revenue by Manufacturer (2020-2025) & (USD Million)
Table 95. Global Plasma Protein Therapeutics Average Price by Manufacturer (2020-2025) & (USD/Unit)
Table 96. Market Position of Manufacturers in Plasma Protein Therapeutics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 97. Head Office and Plasma Protein Therapeutics Production Site of Key Manufacturer
Table 98. Plasma Protein Therapeutics Market: Company Product Type Footprint
Table 99. Plasma Protein Therapeutics Market: Company Product Application Footprint
Table 100. Plasma Protein Therapeutics New Market Entrants and Barriers to Market Entry
Table 101. Plasma Protein Therapeutics Mergers, Acquisition, Agreements, and Collaborations
Table 102. Global Plasma Protein Therapeutics Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 103. Global Plasma Protein Therapeutics Sales Quantity by Region (2020-2025) & (K Units)
Table 104. Global Plasma Protein Therapeutics Sales Quantity by Region (2026-2031) & (K Units)
Table 105. Global Plasma Protein Therapeutics Consumption Value by Region (2020-2025) & (USD Million)
Table 106. Global Plasma Protein Therapeutics Consumption Value by Region (2026-2031) & (USD Million)
Table 107. Global Plasma Protein Therapeutics Average Price by Region (2020-2025) & (USD/Unit)
Table 108. Global Plasma Protein Therapeutics Average Price by Region (2026-2031) & (USD/Unit)
Table 109. Global Plasma Protein Therapeutics Sales Quantity by Type (2020-2025) & (K Units)
Table 110. Global Plasma Protein Therapeutics Sales Quantity by Type (2026-2031) & (K Units)
Table 111. Global Plasma Protein Therapeutics Consumption Value by Type (2020-2025) & (USD Million)
Table 112. Global Plasma Protein Therapeutics Consumption Value by Type (2026-2031) & (USD Million)
Table 113. Global Plasma Protein Therapeutics Average Price by Type (2020-2025) & (USD/Unit)
Table 114. Global Plasma Protein Therapeutics Average Price by Type (2026-2031) & (USD/Unit)
Table 115. Global Plasma Protein Therapeutics Sales Quantity by Application (2020-2025) & (K Units)
Table 116. Global Plasma Protein Therapeutics Sales Quantity by Application (2026-2031) & (K Units)
Table 117. Global Plasma Protein Therapeutics Consumption Value by Application (2020-2025) & (USD Million)
Table 118. Global Plasma Protein Therapeutics Consumption Value by Application (2026-2031) & (USD Million)
Table 119. Global Plasma Protein Therapeutics Average Price by Application (2020-2025) & (USD/Unit)
Table 120. Global Plasma Protein Therapeutics Average Price by Application (2026-2031) & (USD/Unit)
Table 121. North America Plasma Protein Therapeutics Sales Quantity by Type (2020-2025) & (K Units)
Table 122. North America Plasma Protein Therapeutics Sales Quantity by Type (2026-2031) & (K Units)
Table 123. North America Plasma Protein Therapeutics Sales Quantity by Application (2020-2025) & (K Units)
Table 124. North America Plasma Protein Therapeutics Sales Quantity by Application (2026-2031) & (K Units)
Table 125. North America Plasma Protein Therapeutics Sales Quantity by Country (2020-2025) & (K Units)
Table 126. North America Plasma Protein Therapeutics Sales Quantity by Country (2026-2031) & (K Units)
Table 127. North America Plasma Protein Therapeutics Consumption Value by Country (2020-2025) & (USD Million)
Table 128. North America Plasma Protein Therapeutics Consumption Value by Country (2026-2031) & (USD Million)
Table 129. Europe Plasma Protein Therapeutics Sales Quantity by Type (2020-2025) & (K Units)
Table 130. Europe Plasma Protein Therapeutics Sales Quantity by Type (2026-2031) & (K Units)
Table 131. Europe Plasma Protein Therapeutics Sales Quantity by Application (2020-2025) & (K Units)
Table 132. Europe Plasma Protein Therapeutics Sales Quantity by Application (2026-2031) & (K Units)
Table 133. Europe Plasma Protein Therapeutics Sales Quantity by Country (2020-2025) & (K Units)
Table 134. Europe Plasma Protein Therapeutics Sales Quantity by Country (2026-2031) & (K Units)
Table 135. Europe Plasma Protein Therapeutics Consumption Value by Country (2020-2025) & (USD Million)
Table 136. Europe Plasma Protein Therapeutics Consumption Value by Country (2026-2031) & (USD Million)
Table 137. Asia-Pacific Plasma Protein Therapeutics Sales Quantity by Type (2020-2025) & (K Units)
Table 138. Asia-Pacific Plasma Protein Therapeutics Sales Quantity by Type (2026-2031) & (K Units)
Table 139. Asia-Pacific Plasma Protein Therapeutics Sales Quantity by Application (2020-2025) & (K Units)
Table 140. Asia-Pacific Plasma Protein Therapeutics Sales Quantity by Application (2026-2031) & (K Units)
Table 141. Asia-Pacific Plasma Protein Therapeutics Sales Quantity by Region (2020-2025) & (K Units)
Table 142. Asia-Pacific Plasma Protein Therapeutics Sales Quantity by Region (2026-2031) & (K Units)
Table 143. Asia-Pacific Plasma Protein Therapeutics Consumption Value by Region (2020-2025) & (USD Million)
Table 144. Asia-Pacific Plasma Protein Therapeutics Consumption Value by Region (2026-2031) & (USD Million)
Table 145. South America Plasma Protein Therapeutics Sales Quantity by Type (2020-2025) & (K Units)
Table 146. South America Plasma Protein Therapeutics Sales Quantity by Type (2026-2031) & (K Units)
Table 147. South America Plasma Protein Therapeutics Sales Quantity by Application (2020-2025) & (K Units)
Table 148. South America Plasma Protein Therapeutics Sales Quantity by Application (2026-2031) & (K Units)
Table 149. South America Plasma Protein Therapeutics Sales Quantity by Country (2020-2025) & (K Units)
Table 150. South America Plasma Protein Therapeutics Sales Quantity by Country (2026-2031) & (K Units)
Table 151. South America Plasma Protein Therapeutics Consumption Value by Country (2020-2025) & (USD Million)
Table 152. South America Plasma Protein Therapeutics Consumption Value by Country (2026-2031) & (USD Million)
Table 153. Middle East & Africa Plasma Protein Therapeutics Sales Quantity by Type (2020-2025) & (K Units)
Table 154. Middle East & Africa Plasma Protein Therapeutics Sales Quantity by Type (2026-2031) & (K Units)
Table 155. Middle East & Africa Plasma Protein Therapeutics Sales Quantity by Application (2020-2025) & (K Units)
Table 156. Middle East & Africa Plasma Protein Therapeutics Sales Quantity by Application (2026-2031) & (K Units)
Table 157. Middle East & Africa Plasma Protein Therapeutics Sales Quantity by Country (2020-2025) & (K Units)
Table 158. Middle East & Africa Plasma Protein Therapeutics Sales Quantity by Country (2026-2031) & (K Units)
Table 159. Middle East & Africa Plasma Protein Therapeutics Consumption Value by Country (2020-2025) & (USD Million)
Table 160. Middle East & Africa Plasma Protein Therapeutics Consumption Value by Country (2026-2031) & (USD Million)
Table 161. Plasma Protein Therapeutics Raw Material
Table 162. Key Manufacturers of Plasma Protein Therapeutics Raw Materials
Table 163. Plasma Protein Therapeutics Typical Distributors
Table 164. Plasma Protein Therapeutics Typical Customers
LIST OF FIGURES
Figure 1. Plasma Protein Therapeutics Picture
Figure 2. Global Plasma Protein Therapeutics Revenue by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Plasma Protein Therapeutics Revenue Market Share by Type in 2024
Figure 4. Coagulation Factor Examples
Figure 5. Immune Globulin Examples
Figure 6. Albumin Examples
Figure 7. Others Examples
Figure 8. Global Plasma Protein Therapeutics Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 9. Global Plasma Protein Therapeutics Revenue Market Share by Application in 2024
Figure 10. Hemophilia Examples
Figure 11. PID Examples
Figure 12. Others Examples
Figure 13. Global Plasma Protein Therapeutics Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 14. Global Plasma Protein Therapeutics Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 15. Global Plasma Protein Therapeutics Sales Quantity (2020-2031) & (K Units)
Figure 16. Global Plasma Protein Therapeutics Price (2020-2031) & (USD/Unit)
Figure 17. Global Plasma Protein Therapeutics Sales Quantity Market Share by Manufacturer in 2024
Figure 18. Global Plasma Protein Therapeutics Revenue Market Share by Manufacturer in 2024
Figure 19. Producer Shipments of Plasma Protein Therapeutics by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 20. Top 3 Plasma Protein Therapeutics Manufacturer (Revenue) Market Share in 2024
Figure 21. Top 6 Plasma Protein Therapeutics Manufacturer (Revenue) Market Share in 2024
Figure 22. Global Plasma Protein Therapeutics Sales Quantity Market Share by Region (2020-2031)
Figure 23. Global Plasma Protein Therapeutics Consumption Value Market Share by Region (2020-2031)
Figure 24. North America Plasma Protein Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 25. Europe Plasma Protein Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 26. Asia-Pacific Plasma Protein Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 27. South America Plasma Protein Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 28. Middle East & Africa Plasma Protein Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 29. Global Plasma Protein Therapeutics Sales Quantity Market Share by Type (2020-2031)
Figure 30. Global Plasma Protein Therapeutics Consumption Value Market Share by Type (2020-2031)
Figure 31. Global Plasma Protein Therapeutics Average Price by Type (2020-2031) & (USD/Unit)
Figure 32. Global Plasma Protein Therapeutics Sales Quantity Market Share by Application (2020-2031)
Figure 33. Global Plasma Protein Therapeutics Revenue Market Share by Application (2020-2031)
Figure 34. Global Plasma Protein Therapeutics Average Price by Application (2020-2031) & (USD/Unit)
Figure 35. North America Plasma Protein Therapeutics Sales Quantity Market Share by Type (2020-2031)
Figure 36. North America Plasma Protein Therapeutics Sales Quantity Market Share by Application (2020-2031)
Figure 37. North America Plasma Protein Therapeutics Sales Quantity Market Share by Country (2020-2031)
Figure 38. North America Plasma Protein Therapeutics Consumption Value Market Share by Country (2020-2031)
Figure 39. United States Plasma Protein Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 40. Canada Plasma Protein Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 41. Mexico Plasma Protein Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 42. Europe Plasma Protein Therapeutics Sales Quantity Market Share by Type (2020-2031)
Figure 43. Europe Plasma Protein Therapeutics Sales Quantity Market Share by Application (2020-2031)
Figure 44. Europe Plasma Protein Therapeutics Sales Quantity Market Share by Country (2020-2031)
Figure 45. Europe Plasma Protein Therapeutics Consumption Value Market Share by Country (2020-2031)
Figure 46. Germany Plasma Protein Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 47. France Plasma Protein Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 48. United Kingdom Plasma Protein Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 49. Russia Plasma Protein Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 50. Italy Plasma Protein Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 51. Asia-Pacific Plasma Protein Therapeutics Sales Quantity Market Share by Type (2020-2031)
Figure 52. Asia-Pacific Plasma Protein Therapeutics Sales Quantity Market Share by Application (2020-2031)
Figure 53. Asia-Pacific Plasma Protein Therapeutics Sales Quantity Market Share by Region (2020-2031)
Figure 54. Asia-Pacific Plasma Protein Therapeutics Consumption Value Market Share by Region (2020-2031)
Figure 55. China Plasma Protein Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 56. Japan Plasma Protein Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 57. South Korea Plasma Protein Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 58. India Plasma Protein Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 59. Southeast Asia Plasma Protein Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 60. Australia Plasma Protein Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 61. South America Plasma Protein Therapeutics Sales Quantity Market Share by Type (2020-2031)
Figure 62. South America Plasma Protein Therapeutics Sales Quantity Market Share by Application (2020-2031)
Figure 63. South America Plasma Protein Therapeutics Sales Quantity Market Share by Country (2020-2031)
Figure 64. South America Plasma Protein Therapeutics Consumption Value Market Share by Country (2020-2031)
Figure 65. Brazil Plasma Protein Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 66. Argentina Plasma Protein Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 67. Middle East & Africa Plasma Protein Therapeutics Sales Quantity Market Share by Type (2020-2031)
Figure 68. Middle East & Africa Plasma Protein Therapeutics Sales Quantity Market Share by Application (2020-2031)
Figure 69. Middle East & Africa Plasma Protein Therapeutics Sales Quantity Market Share by Country (2020-2031)
Figure 70. Middle East & Africa Plasma Protein Therapeutics Consumption Value Market Share by Country (2020-2031)
Figure 71. Turkey Plasma Protein Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 72. Egypt Plasma Protein Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 73. Saudi Arabia Plasma Protein Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 74. South Africa Plasma Protein Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 75. Plasma Protein Therapeutics Market Drivers
Figure 76. Plasma Protein Therapeutics Market Restraints
Figure 77. Plasma Protein Therapeutics Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Plasma Protein Therapeutics in 2024
Figure 80. Manufacturing Process Analysis of Plasma Protein Therapeutics
Figure 81. Plasma Protein Therapeutics Industrial Chain
Figure 82. Sales Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
Figure 1. Plasma Protein Therapeutics Picture
Figure 2. Global Plasma Protein Therapeutics Revenue by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Plasma Protein Therapeutics Revenue Market Share by Type in 2024
Figure 4. Coagulation Factor Examples
Figure 5. Immune Globulin Examples
Figure 6. Albumin Examples
Figure 7. Others Examples
Figure 8. Global Plasma Protein Therapeutics Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 9. Global Plasma Protein Therapeutics Revenue Market Share by Application in 2024
Figure 10. Hemophilia Examples
Figure 11. PID Examples
Figure 12. Others Examples
Figure 13. Global Plasma Protein Therapeutics Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 14. Global Plasma Protein Therapeutics Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 15. Global Plasma Protein Therapeutics Sales Quantity (2020-2031) & (K Units)
Figure 16. Global Plasma Protein Therapeutics Price (2020-2031) & (USD/Unit)
Figure 17. Global Plasma Protein Therapeutics Sales Quantity Market Share by Manufacturer in 2024
Figure 18. Global Plasma Protein Therapeutics Revenue Market Share by Manufacturer in 2024
Figure 19. Producer Shipments of Plasma Protein Therapeutics by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 20. Top 3 Plasma Protein Therapeutics Manufacturer (Revenue) Market Share in 2024
Figure 21. Top 6 Plasma Protein Therapeutics Manufacturer (Revenue) Market Share in 2024
Figure 22. Global Plasma Protein Therapeutics Sales Quantity Market Share by Region (2020-2031)
Figure 23. Global Plasma Protein Therapeutics Consumption Value Market Share by Region (2020-2031)
Figure 24. North America Plasma Protein Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 25. Europe Plasma Protein Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 26. Asia-Pacific Plasma Protein Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 27. South America Plasma Protein Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 28. Middle East & Africa Plasma Protein Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 29. Global Plasma Protein Therapeutics Sales Quantity Market Share by Type (2020-2031)
Figure 30. Global Plasma Protein Therapeutics Consumption Value Market Share by Type (2020-2031)
Figure 31. Global Plasma Protein Therapeutics Average Price by Type (2020-2031) & (USD/Unit)
Figure 32. Global Plasma Protein Therapeutics Sales Quantity Market Share by Application (2020-2031)
Figure 33. Global Plasma Protein Therapeutics Revenue Market Share by Application (2020-2031)
Figure 34. Global Plasma Protein Therapeutics Average Price by Application (2020-2031) & (USD/Unit)
Figure 35. North America Plasma Protein Therapeutics Sales Quantity Market Share by Type (2020-2031)
Figure 36. North America Plasma Protein Therapeutics Sales Quantity Market Share by Application (2020-2031)
Figure 37. North America Plasma Protein Therapeutics Sales Quantity Market Share by Country (2020-2031)
Figure 38. North America Plasma Protein Therapeutics Consumption Value Market Share by Country (2020-2031)
Figure 39. United States Plasma Protein Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 40. Canada Plasma Protein Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 41. Mexico Plasma Protein Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 42. Europe Plasma Protein Therapeutics Sales Quantity Market Share by Type (2020-2031)
Figure 43. Europe Plasma Protein Therapeutics Sales Quantity Market Share by Application (2020-2031)
Figure 44. Europe Plasma Protein Therapeutics Sales Quantity Market Share by Country (2020-2031)
Figure 45. Europe Plasma Protein Therapeutics Consumption Value Market Share by Country (2020-2031)
Figure 46. Germany Plasma Protein Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 47. France Plasma Protein Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 48. United Kingdom Plasma Protein Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 49. Russia Plasma Protein Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 50. Italy Plasma Protein Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 51. Asia-Pacific Plasma Protein Therapeutics Sales Quantity Market Share by Type (2020-2031)
Figure 52. Asia-Pacific Plasma Protein Therapeutics Sales Quantity Market Share by Application (2020-2031)
Figure 53. Asia-Pacific Plasma Protein Therapeutics Sales Quantity Market Share by Region (2020-2031)
Figure 54. Asia-Pacific Plasma Protein Therapeutics Consumption Value Market Share by Region (2020-2031)
Figure 55. China Plasma Protein Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 56. Japan Plasma Protein Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 57. South Korea Plasma Protein Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 58. India Plasma Protein Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 59. Southeast Asia Plasma Protein Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 60. Australia Plasma Protein Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 61. South America Plasma Protein Therapeutics Sales Quantity Market Share by Type (2020-2031)
Figure 62. South America Plasma Protein Therapeutics Sales Quantity Market Share by Application (2020-2031)
Figure 63. South America Plasma Protein Therapeutics Sales Quantity Market Share by Country (2020-2031)
Figure 64. South America Plasma Protein Therapeutics Consumption Value Market Share by Country (2020-2031)
Figure 65. Brazil Plasma Protein Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 66. Argentina Plasma Protein Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 67. Middle East & Africa Plasma Protein Therapeutics Sales Quantity Market Share by Type (2020-2031)
Figure 68. Middle East & Africa Plasma Protein Therapeutics Sales Quantity Market Share by Application (2020-2031)
Figure 69. Middle East & Africa Plasma Protein Therapeutics Sales Quantity Market Share by Country (2020-2031)
Figure 70. Middle East & Africa Plasma Protein Therapeutics Consumption Value Market Share by Country (2020-2031)
Figure 71. Turkey Plasma Protein Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 72. Egypt Plasma Protein Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 73. Saudi Arabia Plasma Protein Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 74. South Africa Plasma Protein Therapeutics Consumption Value (2020-2031) & (USD Million)
Figure 75. Plasma Protein Therapeutics Market Drivers
Figure 76. Plasma Protein Therapeutics Market Restraints
Figure 77. Plasma Protein Therapeutics Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Plasma Protein Therapeutics in 2024
Figure 80. Manufacturing Process Analysis of Plasma Protein Therapeutics
Figure 81. Plasma Protein Therapeutics Industrial Chain
Figure 82. Sales Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
